Group penalized logistic regression differentiates between benign and malignant ovarian tumors

被引:0
|
作者
Hu, Xuemei [1 ,2 ]
Xie, Ying [3 ]
Yang, Yanlin [4 ]
Jiang, Huifeng [5 ]
机构
[1] Chongqing Technol & Business Univ, Sch Math & Stat, Chongqing 400067, Peoples R China
[2] Chongqing Technol & Business Univ, Chongqing Key Lab Social Econ & Appl Stat, Chongqing 400067, Peoples R China
[3] Chongqing Vocat Coll Sci & Technol, Gen Natl Def Educ Coll, Chongqing 400037, Peoples R China
[4] Chongqing Univ, Sch Econ & Business Adm, Chongqing 400044, Peoples R China
[5] Chongqing Technol & Business Univ, Res Ctr Econ Upper Reaches Yangtse River, Chongqing 400067, Peoples R China
关键词
Ovarian cancer; GCD algorithm; GLASSO/GSCAD/GMCP penalty; Machine learning methods; Deep learning methods; VARIABLE SELECTION; CANCER; CA125; HE-4; ROMA;
D O I
10.1007/s00500-023-09231-4
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
Ovarian cancer is one of the most common types of cancer in women. Correct differentiation between benign and malignant ovarian tumors is of immense importance in medical fields. In this paper, we introduce group penalized logistic regressions to enhance diagnosis accuracy. Firstly, we divide 349 ovarian cancer patients into two sets: one for learning model parameters, and the other for assessing prediction performance, and select 46 variables from 49 traits as the predictor vector to construct GLASSO/GSCAD/GMCP penalized logistic regressions with 11 groups. Secondly, we develop group coordinate descent (GCD) algorithm and its specific pseudo code to simultaneously complete group selection and group estimation, introduce the tenfold cross validation (CV) procedure to select the relatively optimal tuning parameter, and apply the testing set and Youden index to obtain class probability estimator and class index information. Finally, we compute the accuracy, precision, specificity, sensitivity, F1-score and the area under ROC curve (AUC) to assess the prediction performance to the proposed group penalized methods, and found that GLASSO/GSCAD/GMCP penalized logistic regressions outperform three machine learning methods (ANN, artificial neural network; SVM, support vector machine; XGBoost, eXtreme gradient boosting) and three deep learning methods (CNN, convolutional neural network; DNN, deep neural network; RNN, recurrent neural network) in terms of accuracy, F1-score and AUC.
引用
收藏
页码:18565 / 18584
页数:20
相关论文
共 50 条
  • [31] M-CSF levels in benign and malignant ovarian tumors
    Hayashi, M
    Tomobe, K
    Hoshimoto, K
    Ohkura, T
    9TH BIENNIAL MEETING OF THE INTERNATIONL GYNECOLOGIC CANCER SOCIETY, 2002, : 93 - 98
  • [32] OVARIAN ENDOMETRIOID ADENOFIBROMATOUS AND CYSTADENOFIBROMATOUS TUMORS - BENIGN, PROLIFERATING, AND MALIGNANT
    ROTH, LM
    CZERNOBILSKY, B
    LANGLEY, FA
    CANCER, 1981, 48 (08) : 1838 - 1845
  • [33] Immunohistochemical localization of metallothionein in benign and malignant epithelial ovarian tumors
    McCluggage, WG
    Strand, K
    Abdulkadir, A
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2002, 12 (01) : 62 - 65
  • [34] The predictive role of thrombocytosis in benign, borderline and malignant ovarian tumors
    Abdulrahman, Ganiy Opeyemi, Jr.
    Das, Nagindra
    Singh, Kerryn Lutchman
    PLATELETS, 2020, 31 (06) : 795 - 800
  • [35] APOPTOTIC AND PROLIFERATIVE ACTIVITY IN OVARIAN BENIGN,BORDERLINE AND MALIGNANT TUMORS
    刘爱军
    陈乐真
    颜婉嫦
    邱玮璇
    赵昀
    张雅贤
    Chinese Medical Sciences Journal, 2002, (02) : 106 - 111
  • [36] Preservation of fertility in surgery of benign and borderline malignant ovarian tumors
    Guillaume, A.
    Pirrello, O.
    JOURNAL OF VISCERAL SURGERY, 2018, 155 : S17 - S21
  • [37] Plasma fibrinogen levels in patients with benign and malignant ovarian tumors
    Hefler-Frischmuth, Katrin
    Lafleur, Judith
    Hefler, Lukas
    Polterauer, Stephan
    Seebacher, Veronika
    Reinthaller, Alexander
    Grimm, Christoph
    GYNECOLOGIC ONCOLOGY, 2015, 136 (03) : 567 - 570
  • [38] Use of lysophosphatidic acid in the management of benign and malignant ovarian tumors
    Pozlep, B.
    Meleh, M.
    Kobal, B.
    Verdenik, I.
    Osredkar, J.
    Kralj, L. Z.
    Meden-Vrtovec, H.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2007, 28 (05) : 394 - 399
  • [39] Laser polarimetry of bioliguids of patients with benign and malignant ovarian tumors
    Peresunko, AP
    ben Mouhamed, SS
    SIXTH INTERNATIONAL CONFERENCE ON CORRELATION OPTICS, 2003, 5477 : 524 - 529
  • [40] A multivariate logistic regression analysis in predicting malignancy for patients with ovarian tumors
    Hata, K
    Akiba, S
    Hata, T
    Miyazaki, K
    GYNECOLOGIC ONCOLOGY, 1998, 68 (03) : 256 - 262